## LEN: Lennar Corporation - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -7.3% below STRENGTH zone (4.0-10.0%); PEG 2.36 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (51% of avg), momentum weakening (-13.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($109.19)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Eagle Materials Inc (NYSE:EXP) Receives Average Recommendation of "Hold" from Analysts**
- Source: MarketBeat | 20251209T070938 | Somewhat-Bullish | Relevance: 64%
- Eagle Materials Inc. (NYSE:EXP) has received an average "Hold" recommendation from analysts, with a consensus 1-year price target of $243.30. This comes after several analysts recently lowered their price targets. The company reported slightly lower-than-estimated Q3 EPS of $4.23 but revenue that slightly exceeded expectations at $638.9 million, and declared a quarterly dividend of $0.25.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Barclays | $98 | $95 | +3% |
| 2025-12-04 | JP Morgan | $115 | $118 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Barclays | down | Underweight |
| 2025-12-04 | JP Morgan | down | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.00M) |
| Sells | 4 ($0.39M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 52.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (-4.7%)
- Blackrock Inc.: 9.5% (-1.1%)
- JPMORGAN CHASE & CO: 5.0% (+121.1%)
- State Street Corpora: 4.7% (-3.1%)
- Greenhaven Associate: 4.3% (+1.7%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-13.0% 5d) with bearish MACD, trend may be turning.
2. Elevated short interest (12.2%): bears positioning against stock.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.36 elevated, pricing in significant growth expectations. Balance sheet: strong liquidity (10.4x). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $28.9B |
| Beta | 1.40 |
| 52W Range | $98.42 - $158.29 |
| Short Interest | 12.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.36 |
| Forward P/E | 13.1 |
| Current P/E | 14.3 |
| YoY Growth | 9.3% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 5.7% to -7.3% (-13.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 11.3pp (needs >4.0% for momentum thesis). AM_20 at -5.3% indicates price below own 20MA trend. Underperforming sector by 6.4pp, stock-specific weakness. Below SMA200 (0.99x), long-term trend not supportive. MACD histogram bearish (-0.62), momentum weakening. Volume at 51% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -7.29% (CS: 5) | Weak |
| RSI_14 | 39.0 | Neutral |
| MACD Histogram | -0.62 | Bearish |
| vs SMA20 | 0.947x | Below |
| vs SMA50 | 0.945x | Below |
| vs SMA200 | 0.988x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $117.19
- **Stop Loss:** $109.19 (6.8% risk)
- **Target:** $125.19 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 62
- **Position Value:** $7,265.78
- **Portfolio %:** 7.27%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2025-12-16 (Est: $2.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.09 | $2.00 | -4.5% |
| 2025Q2 | $1.94 | $1.90 | -2.0% |
| 2025Q1 | $1.71 | $2.14 | +24.9% |
| 2024Q4 | $4.12 | $4.03 | -2.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*